ENVERIC BIOSCIENCES, INC. Finite-lived Intangible Assets Acquired
ENVERIC BIOSCIENCES, INC. (ENVB) reported Finite-lived Intangible Assets Acquired of $675.00 thousand for the 12-month period ending 2021-12-31, per its 10-K/A filed 2023-06-09.
Discontinued › Notes › Goodwill and Other
us-gaap:FinitelivedIntangibleAssetsAcquired1 · last filed 2023-06-09
- ENVERIC BIOSCIENCES, INC. finite-lived intangible assets acquired for fiscal 2021 was $675.00K.
| Period end | Finite-lived Intangible Assets Acquired 12 month |
|---|---|
| 2021-12-31 | $675.00K 10-K/A · filed 2023-06-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |